Management des Anaphylaxie-Risikos bei Covid-19-Impfung.
HNO Nachr
; 51(1): 18-21, 2021.
Article
in De
| MEDLINE
| ID: mdl-33619418
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
De
Journal:
HNO Nachr
Year:
2021
Document type:
Article
Affiliation country:
Alemania